
Cofepris Halts AstraZeneca Vaccine Registration
Cofepris Halts AstraZeneca Vaccine Registration
347 articles on leadership, communication and professional development.

Cofepris Halts AstraZeneca Vaccine Registration

Sinovac relocates its vaccine plant project from Chile to Colombia due to market considerations

Nutricia, Danone Division, Becomes First B Corp Company in Specialized Nutrition

MSD (Merck) Cancels Oncology Collaboration with Sichuan Kelun Following 22 Billion Dollar Agreement with Daiichi Sankyo

Sanofi Records Historic Loss of 20 Billion in the Stock Market

The distribution sector in Spain has shown clear recognition towards Ingram Micro, one of the leading distributors globally.

Amazon, the e-commerce giant, has announced a revolutionary change in its packaging approach.

Oracle NetSuite marked a milestone at SuiteWorld 2023 by celebrating a quarter century of empowerment to its customers and partners.

With the rise of streaming and the constant search for online entertainment, platforms like Netflix have dominated the global market.

The data center industry in Mexico is experiencing an unprecedented boom.

The world of Human Resources management is constantly evolving, and the emergence of Generative Artificial Intelligence has marked a turning point in this transformation.

Recordati appoints Milan Zdravkovic executive vice president of Research and Development.

SUANFARMA announces a collaboration with Reyoung Pharmaceutical to expand the existing portfolio of anti-infective and antibacterial products.

P&G drives timely breast cancer detection in Mexico

AstraZeneca launches 'The ABC's of Flu' to raise awareness about prevention.

Cofepris approves Pfizer's vaccine against Covid-19 for sale in Mexico.

In an unprecedented move, Microsoft, Amazon and international law enforcement have joined forces to combat tech support scams.

Novo Nordisk is now Europe's most valuable company on the stock exchange.

The American pharmaceutical company Bristol Myers Squibb has announced its agreement to acquire oncology company Mirati Therapeutics for approximately

Abbott, a U.S. pharmaceutical company, will invest around 150 million dollars in the construction of a plant in Querétaro, Mexico.